US FDA grants breakthrough therapy designation to Innate Pharma’s lacutamab for relapsed or refractory Sézary syndrome: Marseille, France Tuesday, February 18, 2025, 12:00 Hrs ...

Innate Pharma has secured US Food and Drug Administration (FDA) breakthrough therapy designation for lacutamab to treat ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to ...

It can lead to rash-like redness, scaly patches or plaques, and tumors. The most common type of cutaneous T-cell lymphoma is called mycosis fungoides. A less common form, Sezary syndrome, can lead to ...

Acitretin (Soriatane ®) and bexarotene are the two orally available retinoids used most commonly for treating MF. These drugs are derivatives of vitamin A and are in the same class of agents as ...

Symptom control is often the goal for patients who have mycosis fungoides, the most common type of cutaneous T-cell lymphoma. Mycosis fungoides tends to advance slowly, so symptom control can help you ...

The inflammation and abnormal scaling, flaking, and cracking of the upper layers of the skin in patients with CTCL leads to considerable itching and discomfort. Generally this can be controlled ...

Without proper treatment, tooth infections can spread to other areas of the body, leading to serious and potentially life threatening complications. A tooth infection, or a tooth abscess, is a ...

The subcutaneous formulation of Opdivo Qvantig reduces administration time to three to five minutes, compared to 30 minutes for the IV version. This formulation offers increased convenience, ...